The Apex Times
Above the Noise
Business Wire
BusinessFTC sends about $9.8 million to roughly 65,000 Walmart wire-transfer victims, company faces renewed scrutiny on payment fraud controlsThe Apex TimesBusinessEvercore ISI Says Apple’s iPhone Duo Pre-Order Demand Is “Solidly Out of the Gate,” With Delivery Dates Pushed to Late JanuaryThe Apex TimesBusinessExxonMobil says stronger refining margins could add $4.5 billion to third-quarter Energy Products profitThe Apex TimesBusinessFAA approval for Boeing 737 MAX 10 appears imminent, but Wall Street still trims outlooksThe Apex TimesBusinessTesla’s earnings track record suggests big stock moves, often to the downsideThe Apex TimesBusinessGoogle’s Gemini heads to Geely’s overseas cars, turning AI assistance into an in-car platformThe Apex TimesBusiness“Walmart recession announcement” used to flag 2008 downturn is reportedly climbing again, economist saysThe Apex TimesBusinessBlackRock’s fixed-income investing is circling around AI-linked credit and emerging-market yields, Yahoo Finance saysThe Apex TimesBusinessMastercard launches a “global money platform” that pairs traditional currencies with stablecoins, building on its BVNK dealThe Apex TimesBusinessSEC approval opens standardized binary options tied to crypto-company metrics, not direct bets on Bitcoin priceThe Apex TimesBusinessCoca-Cola selected as KFC U.S. exclusive fountain beverage supplier starting in 2027The Apex TimesBusinessBarclays flags potential Tesla-SpaceX merger idea as analysts weigh AI, robotics and manufacturing synergiesThe Apex TimesBusinessFTC sends about $9.8 million to roughly 65,000 Walmart wire-transfer victims, company faces renewed scrutiny on payment fraud controlsThe Apex TimesBusinessEvercore ISI Says Apple’s iPhone Duo Pre-Order Demand Is “Solidly Out of the Gate,” With Delivery Dates Pushed to Late JanuaryThe Apex TimesBusinessExxonMobil says stronger refining margins could add $4.5 billion to third-quarter Energy Products profitThe Apex TimesBusinessFAA approval for Boeing 737 MAX 10 appears imminent, but Wall Street still trims outlooksThe Apex TimesBusinessTesla’s earnings track record suggests big stock moves, often to the downsideThe Apex TimesBusinessGoogle’s Gemini heads to Geely’s overseas cars, turning AI assistance into an in-car platformThe Apex TimesBusiness“Walmart recession announcement” used to flag 2008 downturn is reportedly climbing again, economist saysThe Apex TimesBusinessBlackRock’s fixed-income investing is circling around AI-linked credit and emerging-market yields, Yahoo Finance saysThe Apex TimesBusinessMastercard launches a “global money platform” that pairs traditional currencies with stablecoins, building on its BVNK dealThe Apex TimesBusinessSEC approval opens standardized binary options tied to crypto-company metrics, not direct bets on Bitcoin priceThe Apex TimesBusinessCoca-Cola selected as KFC U.S. exclusive fountain beverage supplier starting in 2027The Apex TimesBusinessBarclays flags potential Tesla-SpaceX merger idea as analysts weigh AI, robotics and manufacturing synergiesThe Apex TimesBusinessFTC sends about $9.8 million to roughly 65,000 Walmart wire-transfer victims, company faces renewed scrutiny on payment fraud controlsThe Apex TimesBusinessEvercore ISI Says Apple’s iPhone Duo Pre-Order Demand Is “Solidly Out of the Gate,” With Delivery Dates Pushed to Late JanuaryThe Apex TimesBusinessExxonMobil says stronger refining margins could add $4.5 billion to third-quarter Energy Products profitThe Apex TimesBusinessFAA approval for Boeing 737 MAX 10 appears imminent, but Wall Street still trims outlooksThe Apex TimesBusinessTesla’s earnings track record suggests big stock moves, often to the downsideThe Apex TimesBusinessGoogle’s Gemini heads to Geely’s overseas cars, turning AI assistance into an in-car platformThe Apex TimesBusiness“Walmart recession announcement” used to flag 2008 downturn is reportedly climbing again, economist saysThe Apex TimesBusinessBlackRock’s fixed-income investing is circling around AI-linked credit and emerging-market yields, Yahoo Finance saysThe Apex TimesBusinessMastercard launches a “global money platform” that pairs traditional currencies with stablecoins, building on its BVNK dealThe Apex TimesBusinessSEC approval opens standardized binary options tied to crypto-company metrics, not direct bets on Bitcoin priceThe Apex TimesBusinessCoca-Cola selected as KFC U.S. exclusive fountain beverage supplier starting in 2027The Apex TimesBusinessBarclays flags potential Tesla-SpaceX merger idea as analysts weigh AI, robotics and manufacturing synergiesThe Apex TimesBusinessFTC sends about $9.8 million to roughly 65,000 Walmart wire-transfer victims, company faces renewed scrutiny on payment fraud controlsThe Apex TimesBusinessEvercore ISI Says Apple’s iPhone Duo Pre-Order Demand Is “Solidly Out of the Gate,” With Delivery Dates Pushed to Late JanuaryThe Apex TimesBusinessExxonMobil says stronger refining margins could add $4.5 billion to third-quarter Energy Products profitThe Apex TimesBusinessFAA approval for Boeing 737 MAX 10 appears imminent, but Wall Street still trims outlooksThe Apex TimesBusinessTesla’s earnings track record suggests big stock moves, often to the downsideThe Apex TimesBusinessGoogle’s Gemini heads to Geely’s overseas cars, turning AI assistance into an in-car platformThe Apex TimesBusiness“Walmart recession announcement” used to flag 2008 downturn is reportedly climbing again, economist saysThe Apex TimesBusinessBlackRock’s fixed-income investing is circling around AI-linked credit and emerging-market yields, Yahoo Finance saysThe Apex TimesBusinessMastercard launches a “global money platform” that pairs traditional currencies with stablecoins, building on its BVNK dealThe Apex TimesBusinessSEC approval opens standardized binary options tied to crypto-company metrics, not direct bets on Bitcoin priceThe Apex TimesBusinessCoca-Cola selected as KFC U.S. exclusive fountain beverage supplier starting in 2027The Apex TimesBusinessBarclays flags potential Tesla-SpaceX merger idea as analysts weigh AI, robotics and manufacturing synergiesThe Apex Times
Back to front
DBV Technologies CEO to Take Part in Goldman Sachs Global Healthcare Fireside Chat on June 9
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 7, 6:59 PM EDT

DBV Technologies CEO to Take Part in Goldman Sachs Global Healthcare Fireside Chat on June 9

DBV Technologies says Daniel Tassé will join a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference, with a live webcast and an archived replay available for 90 days.

By The Apex Times Newsroom2 min readAI-assisted Apex article

Châtillon, France-based DBV Technologies said its chief executive, Daniel Tassé, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 9:20 a.m. Eastern time in Miami, Florida.

The company said the fireside chat will be webcast live and that an archived replay will be available for 90 days after the event, with the session listed on DBV’s investor-events page under upcoming events for June 9, 2026.

DBV Technologies describes itself as a late-stage biopharmaceutical company focused on food allergies and other immunologic conditions with significant unmet medical need. Its core approach centers on VIASKIN, an over-the-skin (epicutaneous) patch intended to deliver very small quantities of biologically active compounds to the immune system.

The company’s materials explain that its epicutaneous immunotherapy program, known as EPIT, is designed to introduce microgram amounts of a compound through intact skin. DBV says the goal is to help modify an underlying allergy by “re-educating” the immune system, with the patch meant to drive desensitization to an allergen.

DBV also outlined the broader platform context behind the upcoming conference engagement. In its description of ongoing programs, the company said it is investigating VIASKIN patch technology for food allergies, and it referenced clinical trials for VIASKIN Peanut in peanut-allergic children, including toddlers aged 1 to 3 and children aged 4 to 7.

For investors, the practical significance of such conference participation is that it can provide management an opportunity to address investor questions on strategy, timelines, and clinical or regulatory planning without the formal structure of a quarterly earnings call. In DBV’s case, however, the announcement itself does not specify what topics will be covered in the fireside chat.

DBV did not provide any additional clinical or financial data in the announcement. It did not disclose a detailed agenda, expected Q&A themes, or any guidance updates tied to the conference, beyond indicating that the webcast will be accessible live and replayed for 90 days.

Why It Matters

  • Management participation in major healthcare conferences is often used to reinforce strategy and respond to investor questions, particularly for clinical-stage and late-stage biopharma companies.
  • For DBV, the fireside chat timing in early June places it close to mid-year investor planning, which can shape how shareholders interpret near-term milestones.
  • Because the announcement includes webcast and replay access but limited substantive new information, the main value may be Q&A rather than new disclosed results.
  • Investors will likely watch for any management commentary on clinical development momentum and regulatory expectations, even though the company did not specify those topics in advance.

Sources

Key Facts

  • DBV Technologies said CEO Daniel Tassé will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 9:20 a.m. Eastern time.
  • The event is scheduled in Miami, Florida, according to DBV’s announcement.
  • DBV stated the fireside chat will be available via a live webcast and an archived replay for 90 days after the event.
  • DBV described itself as a late-stage biopharmaceutical company focused on food allergies and other immunologic conditions with unmet medical need.
  • The company’s approach centers on VIASKIN patch technology and EPIT, which DBV describes as epicutaneous immunotherapy delivering microgram amounts through intact skin.
  • DBV said it has ongoing clinical trials of VIASKIN Peanut in peanut-allergic toddlers (1 to 3 years old) and children (4 to 7 years old).

Finance Related

DBV Technologies CEO to Take Part in Goldman Sachs Global Healthcare Fireside Chat on June 9 | The Apex Times